Durham, North Carolina — According to state and local economic development sources Taysha Gene Therapies plans to invest $75,000,000.00 to build out 187,000 square feet of new space in Durham. The company plans to occupy the new space in Durham, on or about October 1, 2022. According to the company website We want to do more than just treat monogenic CNS disease. We want to eradicate it. At Taysha Gene Therapies, we believe the patient always comes first. This is why we are singularly focused on discovering, developing and commercializing gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), both in rare and large patient populations. We were founded in partnership with The University of Texas Southwestern Medical Center (UT Southwestern) to develop and commercialize transformative gene therapy treatments. Together with UT Southwestern, we have created a powerful engine to develop transformative therapies with the potential to dramatically improve patients’ lives.

To learn more about Taysha Gene Therapies, visit http://tayshagtx.com/

Company Contact:
RA Session, Chief Executive Officer
https://www.linkedin.com/in/r-a-session-ii-bba8178/
214-612-0000

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved